123 related articles for article (PubMed ID: 38088568)
21. DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice.
Ma M; Hasegawa Y; Koibuchi N; Toyama K; Uekawa K; Nakagawa T; Lin B; Kim-Mitsuyama S
Cardiovasc Diabetol; 2015 May; 14():54. PubMed ID: 25986579
[TBL] [Abstract][Full Text] [Related]
22. The role for endoplasmic reticulum stress in diabetes mellitus.
Eizirik DL; Cardozo AK; Cnop M
Endocr Rev; 2008 Feb; 29(1):42-61. PubMed ID: 18048764
[TBL] [Abstract][Full Text] [Related]
23. Dysregulated UPR and ER Stress Related to a Mutation in the
Yagil C; Varadi-Levi R; Ifrach C; Yagil Y
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674879
[TBL] [Abstract][Full Text] [Related]
24. Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2).
Katsuno T; Shiraiwa T; Iwasaki S; Park H; Watanabe N; Kaneko S; Terasaki J; Hanafusa T; Imagawa A; Shimomura I; Ikegami H; Koyama H; Namba M; Miyagawa JI;
Adv Ther; 2021 Mar; 38(3):1514-1535. PubMed ID: 33507500
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.
Han SY; Yoon SA; Han BG; Kim SG; Jo YI; Jeong KH; Oh KH; Park HC; Park SH; Kang SW; Na KR; Kang SW; Kim NH; Jang Y; Kim B; Shin S; Cha DR
Diabetes Obes Metab; 2018 Feb; 20(2):292-300. PubMed ID: 28719008
[TBL] [Abstract][Full Text] [Related]
26. Effects of combining linagliptin treatment with BI-38335, a novel SGLT2 inhibitor, on pancreatic islet function and inflammation in db/db mice.
Chen L; Klein T; Leung PS
Curr Mol Med; 2012 Sep; 12(8):995-1004. PubMed ID: 22804249
[TBL] [Abstract][Full Text] [Related]
27. Effect of Linagliptin on Incretin-axis and Glycaemic Variability in T1DM.
Mukherjee S; Bhadada SK; Sachdeva N; Badal D; Bhansali S; Dutta P; Bhansali A
J Assoc Physicians India; 2018 Jul; 66(7):28-32. PubMed ID: 31325257
[TBL] [Abstract][Full Text] [Related]
28. Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus.
Sheu WH; Park SW; Gong Y; Pinnetti S; Bhattacharya S; Patel S; Seck T; Woerle HJ
Curr Med Res Opin; 2015 Mar; 31(3):503-12. PubMed ID: 25629790
[TBL] [Abstract][Full Text] [Related]
29. A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus.
Galán M; Kassan M; Choi SK; Partyka M; Trebak M; Henrion D; Matrougui K
Hypertension; 2012 Jul; 60(1):71-80. PubMed ID: 22665120
[TBL] [Abstract][Full Text] [Related]
30. Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial.
Parthan G; Bhansali S; Kurpad AV; Walia R; Bhat K; Bhansali A
BMC Pharmacol Toxicol; 2018 Jul; 19(1):38. PubMed ID: 29970184
[TBL] [Abstract][Full Text] [Related]
31. Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study.
Liu SC; Lee CC; Chuang SM; Sun FJ; Zeng YH
Diabetes Metab; 2021 May; 47(3):101184. PubMed ID: 32827752
[TBL] [Abstract][Full Text] [Related]
32. Endoplasmic reticulum stress is involved in granulosa cell apoptosis during follicular atresia in goat ovaries.
Lin P; Yang Y; Li X; Chen F; Cui C; Hu L; Li Q; Liu W; Jin Y
Mol Reprod Dev; 2012 Jun; 79(6):423-32. PubMed ID: 22532439
[TBL] [Abstract][Full Text] [Related]
33. Targeting IRE1α and PERK in the endoplasmic reticulum stress pathway attenuates fatty acid-induced insulin resistance in bovine hepatocytes.
Fang Z; Gao W; Jiang Q; Loor JJ; Zhao C; Du X; Zhang M; Song Y; Wang Z; Liu G; Li X; Lei L
J Dairy Sci; 2022 Aug; 105(8):6895-6908. PubMed ID: 35840398
[TBL] [Abstract][Full Text] [Related]
34. Effects of Linagliptin on Pancreatic
Zhang Y; Fava GE; Wu M; Htun W; Klein T; Fonseca VA; Wu H
J Endocr Soc; 2017 Oct; 1(10):1224-1234. PubMed ID: 29264448
[TBL] [Abstract][Full Text] [Related]
35. Tauroursodeoxycholic Acid Alleviates Endoplasmic Reticulum Stress-Mediated Visual Deficits in Diabetic tie2-TNF Transgenic Mice via TGR5 Signaling.
Lenin R; Jha KA; Gentry J; Shrestha A; Culp EV; Vaithianathan T; Gangaraju R
J Ocul Pharmacol Ther; 2023 Mar; 39(2):159-174. PubMed ID: 36791327
[No Abstract] [Full Text] [Related]
36. Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet.
Cho EJ; Yoon JH; Kwak MS; Jang ES; Lee JH; Yu SJ; Kim YJ; Kim CY; Lee HS
Dig Dis Sci; 2014 Jul; 59(7):1461-74. PubMed ID: 24865256
[TBL] [Abstract][Full Text] [Related]
37. The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin.
Kern M; Klöting N; Mark M; Mayoux E; Klein T; Blüher M
Metabolism; 2016 Feb; 65(2):114-23. PubMed ID: 26773934
[TBL] [Abstract][Full Text] [Related]
38. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure.
Vandewynckel YP; Laukens D; Devisscher L; Paridaens A; Bogaerts E; Verhelst X; Van den Bussche A; Raevens S; Van Steenkiste C; Van Troys M; Ampe C; Descamps B; Vanhove C; Govaere O; Geerts A; Van Vlierberghe H
Oncotarget; 2015 Sep; 6(29):28011-25. PubMed ID: 26293671
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial.
Araki E; Unno Y; Tanaka Y; Sakamoto W; Miyamoto Y
Adv Ther; 2019 Oct; 36(10):2697-2711. PubMed ID: 31482511
[TBL] [Abstract][Full Text] [Related]
40. Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK.
Jin J; Ma Y; Tong X; Yang W; Dai Y; Pan Y; Ren P; Liu L; Fan HY; Zhang Y; Zhang S
Hum Reprod; 2020 May; 35(5):1145-1158. PubMed ID: 32372097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
